Bone mineral changes and cardiovascular effects among female athletes with chronic menstrual dysfunction

Asian Journal of Sports Medicine

Volumn 3, Issue 1, 2012, Pages 53-59

  Soleimany, Ghazaleh ^a   Dadgostar, Haleh ^a   Lotfian, Sara ^a   Moradi Lakeh, Mazyar ^a   Dadgostar, Elham ^b   Movaseghi, Shafieh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Sports Medicine Federation of Islamic Republic of Iran   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bone Mineral Density; Cardiovascular Risk Factors; Female Athletes; Oligomenorrhea

Indexed keywords

EID: 84867416821     PISSN: 2008000X     EISSN: 20087209     Source Type: Journal    
DOI: 10.5812/asjsm.34730     Document Type: Article

References (24)

1. Nattiv A, Loucks AB, Manore MM, et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007;39:1867-82.
2. Golden NH. The adolescent: vulnerable to develop an eating disorder and at high risk for long-term sequelae. Ann N Y Acad Sci 1997; 817:94-7.
3. Hoch AZ, Lal S, Jurva JW, Gutterman DD. The female athlete triad and cardiovascular dysfunction. Phys Med Rehabil Clin N Am 2007;18:385-400.
4. Hergenroeder AC, Smith EO, Shypailo R, et al. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol 1997;176: 1017-25.
5. Friday KE, Drinkwater BL, Bruemmer B, et al. Elevated plasma low-density lipoprotein and high-density lipoprotein cholesterol levels in amenorrheic athletes: effects of endogenous hormone status and nutrient intake. J Clin Endocrinol Metab 1993;77:1605-9.
6. O'Donnell E, De Souza MJ. The cardiovascular effects of chronic hypoestrogenism in amenorrhoeic athletes: a critical review. Sports Med 2004;34:601-27.
7. Dadgostar H, Razi M, Aleyasin A, et al. The relation between athletic sports and prevalence of amenorrhea and oligomenorrhea in Iranian female athletes. Sports Med Arthrosc Rehabil Ther Technol 2009;1:16.
8. Diaz A, Laufer MR, Breech LL. Menstruation in girls and adolescents using the menstrual cycle as a vital sign. Pediatrics 2006; 118:2245-50.
9. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468-89
10. Leib ES, Lewiecki EM, Binkley N, Hamdy RC. Official positions of the International Society for Clinical Densitometry. South Med J 2004;97:107-10.
11. Bernadette L Matthews, Kim L Bennell. Bone Health and Young Females. Journal of women Health physical Therapy 2005;29:3:19-27.
12. Dequeker J, Nijs J, Verstraeten A, et al. Genetic determinants of bone mineral content at the spine and radius: a twin study. Bone 1987;8:207-9
13. Case T, Lemieux S, Kennedy SH, Lewis GF. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 1999;25:187-93.
14. Feillet F, Feillet-Coudray C, Bard JM, Parra HJ, Favre E, Kabuth B, et al. Plasma cholesterol and endogenous cholesterol synthesis during refeeding in anorexia nervosa. Clin Chim Acta 2000;294:45-56.
15. Cumming DC. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy. Arch Intern Med 1996;156: 21935.
16. Gremion G, Rizzoli R, Slosman D, et al. Oligo-amenorrheic long-distance runners may lose more bone in spine than in femur. Med Sci Sports Exerc 2001;33:15-21
17. Cobb KL, Bachrach LK, Sowers M, et al. The effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Exerc 2007;39:1464-73.
18. Gibson JH, Mitchell A, Reeve J, Harries MG. Treatment of reduced bone mineral density in athletic amenorrhea: a pilot study. Osteoporos Int 1999;10:284-9.
19. Friday KE, Drinkwater BL, Bruemmer B, et al. Elevated plasma low-density lipoprotein and high-density lipoprotein cholesterol levels in amenorrheic athletes: effects of endogenous hormone status and nutrient intake. J Clin Endocrinol Metab 1993;77:1605-9.
20. Rickenlund A, Thoren M, Nybacka A, et al. Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance. Hum Reprod 2010;25:85-93.
21. Loucks AB, Thuma JR. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab 2003;88:297-311.
22. Cid MC, Schnaper HW, Kleinman HK. Estrogens and the vascular endothelium. Ann N Y Acad Sci 2002;966:143-57.
23. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.
24. Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipidmodifying therapy. J Intern Med 2004;255:188-205.